Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients-Reference-Cited by-同舟云学术

Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients

Published:2020-06-17 Issue:12 Volume:20 Page:3529-3537
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Zwart Auke E. S.¹^ORCID,Riezebos‐Brilman Annelies²³,Alffenaar Jan‐Willem C.⁴⁵⁶⁷,Heuvel Edwin R.⁸,Gan Christiaan Tji¹,Bij Wim¹,Kerstjens Huib A. M.¹,Verschuuren Erik A. M.¹

Affiliation:

1. Department of Pulmonary Diseases and Tuberculosis University Medical Centre GroningenUniversity of Groningen Groningen The Netherlands

2. Department of Medical Microbiology University Medical Centre UtrechtUniversity of Utrecht Utrecht The Netherlands

3. Department of Medical Microbiology University Medical Centre GroningenUniversity of Groningen Groningen The Netherlands

4. Department of Clinical Pharmacy and Pharmacology University Medical Centre GroningenUniversity of Groningen Groningen The Netherlands

5. Faculty of Medicine and Health School of Pharmacy University of Sydney Sydney New South Wales Australia

6. Westmead Hospital Sydney New South Wales Australia

7. Marie Bashir Institute for Infectious Diseases and Biosecurity Sydney New South Wales Australia

8. Department of Mathematics and Computer Science Eindhoven University of Technology Eindhoven The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16073

Reference43 articles.

1. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network

2. Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection

3. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin

4. Human Metapneumovirus in Lung Transplant Recipients and Comparison to Respiratory Syncytial Virus

5. Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 infection is mild and has minimal impact on lung function in well vaccinated and widely treated lung transplant recipients;The Journal of Heart and Lung Transplantation;2024-06

2. Determinants of radiological patterns and severity in immunocompromised adults with Metapneumovirus infection;Respiratory Medicine;2024-06

3. The respiratory syncytial virus vaccines are here: Implications for solid organ transplantation;American Journal of Transplantation;2024-06

4. Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy;Infection;2024-04-24

5. The changing landscape of infections in the lung transplant recipient;Current Opinion in Pulmonary Medicine;2024-02-26